发明名称 Nano-scale contrast agents and methods of use
摘要 Compositions and methods are disclosed for evaluating a subject's vasculature integrity, for differentiating between a malignant lesion and a benign lesion, for evaluating the accessibility of a tumor to nano-sized therapeutics, for treating tumors, and for live or real time monitoring of a nano-probe's biodistribution.
申请公布号 US8911708(B2) 申请公布日期 2014.12.16
申请号 US201213717455 申请日期 2012.12.17
申请人 Marval Pharma, Inc. 发明人 Annapragada Ananth;Bellamkonda Ravi V.;Karathanasis Efstathios;Lebovitz Russell M.
分类号 A61K49/00;A61K9/127;A61K49/04 主分类号 A61K49/00
代理机构 Benesch, Friedlander, Coplan & Aronoff LLP 代理人 Benesch, Friedlander, Coplan & Aronoff LLP ;Kern Benjamen E.;Anderson Kraig K.
主权项 1. A method for evaluating a subject's vasculature integrity, the method comprising: introducing a composition into the subject's vasculature, the composition comprising: liposomes, the liposomes encapsulating one or more iodinated nonradioactive contrast-enhancing agents, and the liposomes comprising:cholesterol,at least one phospholipid, andat least one phospholipid which is derivatized with a polymer chain,wherein the average diameter of the liposomes is less than 150 nanometers; generating images of the subject's vasculature; and analyzing the images to detect a leak in the subject's vasculature, the leak in the subject's vasculature being caused by inflammation or angiogenesis, provided that the inflammation or angiogenesis excludes cancer, stroke, aneurism, healing, and trauma.
地址 New York NY US